Users Coming Off Slimming Medications Put On Pounds Far More Rapidly Compared to Dieters

Fresh analysis indicates that individuals who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop traditional lifestyle programs.

Published data in a major health publication demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying these medications should be cognizant of the potential of quick weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.

Such speed of regain suggests a reversion to pre-treatment mass in about a year and a half.

Comparing Therapies

The research, which looked at 37 of studies involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.

The team note that individuals who shed pounds through lifestyle changes alone generally experience a more gradual creep back—around 100 grams monthly—post-intervention.

Understanding the Quick Rebound

Doctors propose the mechanism of the injections is key to understanding the accelerated rebound.

The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Sustained high doses of the hormone levels far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating a significant risk."

An Ongoing Condition?

Medical guidelines recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Professionals contend that, considering the likelihood of weight regain, the therapy should be considered ongoing.

This view is echoed by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," similar to managing conditions like high blood pressure.

Patient Accounts

Individuals who have discontinued the medication describe a sudden resurgence of appetite.

"It felt as if a switch activating and you're instantly extremely hungry," recalled a patient.

This difficulty is compounded if users have not established permanent lifestyle or habit modifications during therapy.

Significant Adoption

Figures show that millions of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.

• Adoption is more common among women than males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

Finally, researchers stress that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic fix and lasting health benefits hinges on ongoing lifestyle management.